Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin
Authors:
- G.A. ColesGCG.A. Coles
- J.D. WilliamsJWJ.D. Williams
- M.E. DaviesMDM.E. Davies
- R.D. HuttonRHR.D. Hutton
- D.L. CochlinDCD.L. Cochlin
- N.P. LewisNLN.P. Lewis
- K.A.A. FoxKFK.A.A. Fox
- M.J. SaundersMSM.J. Saunders
- 1 March 1990
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 335 (8688) , 489-493
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Vascular changes in hemodialysis patients in response to recombinant human erythropoietinKidney International, 1989
- Impact of left ventricular hypertrophy on survival in end-stage renal diseaseKidney International, 1989
- Blood Rheology and Hypertension in Hemodialysis Patients Treated with ErythropoietinAmerican Journal of Nephrology, 1988
- HYPERTENSION, BLOOD VISCOSITY, AND CARDIOVASCULAR MORBIDITY IN RENAL FAILURE: IMPLICATIONS OF ERYTHROPOIETIN THERAPYThe Lancet, 1988
- Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertensionThe American Journal of Cardiology, 1984
- Determination of anaerobic threshold for assessment of functional state in patients with chronic heart failure.Circulation, 1983
- Ischemic heart disease in patients with uremia undergoing maintenance hemodialysisKidney International, 1979
- Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.Circulation, 1977
- Hemodynamics of Uremic AnemiaCirculation, 1971
- The Hemodynamic Response to Chronic AnemiaCirculation, 1969